Patanase and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Patanase (olopatadine hydrochloride), especially for people who are female, 60+ old, also take Miralax, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Patanase. It is created by eHealthMe based on reports of 1,396 people who have side effects when taking Patanase from the FDA, and is updated regularly.

What is Patanase?

Patanase has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 1,514 Patanase users. Check the latest studies of Patanase.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,568 drugs and 4,588 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On Jul, 10, 2026

1,396 people reported to have side effects when taking Patanase.
Among them, 22 people (1.58%) have Appetite - decreased.

Could Patanase cause Appetite - decreased?

Among these 22 people:

What is the gender of people who have Appetite - decreased when taking Patanase? *

female: 68.18 %
male: 31.82 %

What is the age of people who have Appetite - decreased when taking Patanase? *

What are other drugs people take besides Patanase? *

What are other side effects people have besides Appetite - decreased? *

Nausea (feeling of having an urge to vomit): 11 people, 50.00%
Muscle Aches (muscle pain): 9 people, 40.91%
Pain: 8 people, 36.36%
Fever: 7 people, 31.82%
Fatigue (feeling of tiredness): 7 people, 31.82%
Weakness: 6 people, 27.27%
Headache (pain in head): 6 people, 27.27%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 6 people, 27.27%
Chills (felling of cold): 6 people, 27.27%
Sinus Congestion (blockage of sinus): 5 people, 22.73%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 54.55%
Pain: 7 people, 31.82%
Sinusitis (inflammation of sinus): 6 people, 27.27%
Constipation: 6 people, 27.27%
High Blood Cholesterol: 6 people, 27.27%
Cystic Fibrosis (disease of the secretary glands): 6 people, 27.27%
Insomnia (sleeplessness): 5 people, 22.73%
Sinus Disorder (disease of sinus): 4 people, 18.18%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 4 people, 18.18%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 4 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Patanase and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Patanase:

Patanase (1,514 reports)

Browse all side effects of Patanase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,568 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olopatadine hydrochloride (the active ingredients of Patanase) and Patanase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.